Literature DB >> 22015947

Demyelination and remyelination in anatomically distinct regions of the corpus callosum following cuprizone intoxication.

Andrew J Steelman1, Jeffrey P Thompson, Jianrong Li.   

Abstract

Multiple sclerosis is a chronic demyelinating disease of the central nervous system. Spontaneous remyelination during early disease stages is thought to preserve and partially restore function. However, this process ceases in later stages despite the presence of pre-oligodendrocytes. Cuprizone-induced demyelination is a useful model with which to study the remyelination process. Previous studies have demonstrated heterogeneities in demyelination in individual animals. Here we investigated regional differences in demyelination and remyelination within the corpus callosum. C57BL/6 mice were fed 0.2% cuprizone for 5 weeks to induce demyelination. Remyelination was examined 2-5 weeks after cuprizone withdrawal. Immunohistochemistry and electron microscopy were used to quantify regional differences in demyelination, gliosis, and remyelination. We found that, while demyelination was limited in the rostral region of corpus callosum, nearly complete demyelination occurred in the caudal callosum, beginning at approximately -0.5mm from bregma. Astrogliosis and microgliosis were correlated with demyelination and differed between the rostral and caudal callosal structures. Remyelination upon cessation of cuprizone ensued at different rates with splenium remyelinating faster than dorsal hippocampal commissure. Our data show anatomical differences of cuprizone-induced demyelination and remyelination in the corpus callosum and the importance of examining specific callosal regions in myelin repair studies using this model.
Copyright © 2011 Elsevier Ireland Ltd and the Japan Neuroscience Society. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22015947      PMCID: PMC3230728          DOI: 10.1016/j.neures.2011.10.002

Source DB:  PubMed          Journal:  Neurosci Res        ISSN: 0168-0102            Impact factor:   3.304


  44 in total

1.  Preferential occult injury of corpus callosum in multiple sclerosis measured by diffusion tensor imaging.

Authors:  Yulin Ge; Meng Law; Glyn Johnson; Joseph Herbert; James S Babb; Lois J Mannon; Robert I Grossman
Journal:  J Magn Reson Imaging       Date:  2004-07       Impact factor: 4.813

2.  Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion.

Authors:  Michael H Barnett; John W Prineas
Journal:  Ann Neurol       Date:  2004-04       Impact factor: 10.422

3.  Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination.

Authors:  C Lucchinetti; W Brück; J Parisi; B Scheithauer; M Rodriguez; H Lassmann
Journal:  Ann Neurol       Date:  2000-06       Impact factor: 10.422

4.  Demyelination of the superior cerebellar peduncle in the mouse induced by cuprizone.

Authors:  W F Blakemore
Journal:  J Neurol Sci       Date:  1973-09       Impact factor: 3.181

5.  Status spongiosus of CNS and hepatic changes induced by cuprizone (biscyclohexanone oxalyldihydrazone).

Authors:  K Suzuki; Y Kikkawa
Journal:  Am J Pathol       Date:  1969-02       Impact factor: 4.307

6.  Isonicotinic acid hydrazide-induced spongy degeneration of the white matter in the brains of Pekin ducks.

Authors:  W W Carlton; G Kreutzberg
Journal:  Am J Pathol       Date:  1966-01       Impact factor: 4.307

Review 7.  The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system.

Authors:  G K Matsushima; P Morell
Journal:  Brain Pathol       Date:  2001-01       Impact factor: 6.508

8.  TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination.

Authors:  H A Arnett; J Mason; M Marino; K Suzuki; G K Matsushima; J P Ting
Journal:  Nat Neurosci       Date:  2001-11       Impact factor: 24.884

9.  Central nervous system demyelination and remyelination in the mouse: an ultrastructural study of cuprizone toxicity.

Authors:  S K Ludwin
Journal:  Lab Invest       Date:  1978-12       Impact factor: 5.662

10.  Quantifying the early stages of remyelination following cuprizone-induced demyelination.

Authors:  Mark F Stidworthy; Stephane Genoud; Ueli Suter; Ned Mantei; Robin J M Franklin
Journal:  Brain Pathol       Date:  2003-07       Impact factor: 6.508

View more
  66 in total

1.  In vivo quantification of demyelination and recovery using compartment-specific diffusion MRI metrics validated by electron microscopy.

Authors:  Ileana O Jelescu; Magdalena Zurek; Kerryanne V Winters; Jelle Veraart; Anjali Rajaratnam; Nathanael S Kim; James S Babb; Timothy M Shepherd; Dmitry S Novikov; Sungheon G Kim; Els Fieremans
Journal:  Neuroimage       Date:  2016-02-11       Impact factor: 6.556

2.  Neural Stem Cells of the Subventricular Zone Contribute to Neuroprotection of the Corpus Callosum after Cuprizone-Induced Demyelination.

Authors:  Erica Butti; Marco Bacigaluppi; Linda Chaabane; Francesca Ruffini; Elena Brambilla; Giulia Berera; Carolina Montonati; Angelo Quattrini; Gianvito Martino
Journal:  J Neurosci       Date:  2019-05-28       Impact factor: 6.167

3.  Diffusion tensor imaging identifies aspects of therapeutic estrogen receptor β ligand-induced remyelination in a mouse model of multiple sclerosis.

Authors:  Kelley C Atkinson; Jeong Bin Lee; Jonathan P C Hasselmann; Sung Hoon Kim; Alyson Drew; Joselyn Soto; John A Katzenellenbogen; Neil G Harris; Andre Obenaus; Seema K Tiwari-Woodruff
Journal:  Neurobiol Dis       Date:  2019-06-18       Impact factor: 5.996

4.  Microglial Hv1 proton channel promotes cuprizone-induced demyelination through oxidative damage.

Authors:  Junli Liu; Daishi Tian; Madhuvika Murugan; Ukpong B Eyo; Cheryl F Dreyfus; Wei Wang; Long-Jun Wu
Journal:  J Neurochem       Date:  2015-08-11       Impact factor: 5.372

5.  High-resolution magnetic resonance microscopy and diffusion tensor imaging to assess brain structural abnormalities in the murine mucopolysaccharidosis VII model.

Authors:  Manoj Kumar; Ilya M Nasrallah; Sungheon Kim; Ranjit Ittyerah; Stephen Pickup; Joel Li; Michael K Parente; John H Wolfe; Harish Poptani
Journal:  J Neuropathol Exp Neurol       Date:  2014-01       Impact factor: 3.685

6.  Cuprizone Administration Alters the Iron Metabolism in the Mouse Model of Multiple Sclerosis.

Authors:  E Varga; E Pandur; H Abrahám; A Horváth; P Ács; S Komoly; A Miseta; K Sipos
Journal:  Cell Mol Neurobiol       Date:  2018-02-20       Impact factor: 5.046

Review 7.  The development of myelin repair agents for treatment of multiple sclerosis: progress and challenges.

Authors:  Robert P Murphy; Keith J Murphy; Mark Pickering
Journal:  Bioengineered       Date:  2012-11-12       Impact factor: 3.269

8.  Protective effects of melatonin against mitochondrial injury in a mouse model of multiple sclerosis.

Authors:  Iraj Ragerdi Kashani; Zahra Rajabi; Mohammad Akbari; Gholamreza Hassanzadeh; Alireza Mohseni; Mohammadtaha Kouchakinejad Eramsadati; Kheirollah Rafiee; Cordian Beyer; Markus Kipp; Adib Zendedel
Journal:  Exp Brain Res       Date:  2014-05-06       Impact factor: 1.972

9.  Functional Effects of Cuprizone-Induced Demyelination in the Presence of the mTOR-Inhibitor Rapamycin.

Authors:  Hana Yamate-Morgan; Kelli Lauderdale; Joshua Horeczko; Urja Merchant; Seema K Tiwari-Woodruff
Journal:  Neuroscience       Date:  2019-01-29       Impact factor: 3.590

10.  Activation of oligodendroglial Stat3 is required for efficient remyelination.

Authors:  Andrew J Steelman; Yun Zhou; Hisami Koito; SunJa Kim; H Ross Payne; Q Richard Lu; Jianrong Li
Journal:  Neurobiol Dis       Date:  2016-04-06       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.